Today, a study conducted in Germany was published describing the occurrence of cerebrovascular events, especially cerebral sinus and cerebral venous thrombosis (CVT), after vaccination against SARS-CoV-2. A main finding was that not only younger women had a higher risk of CVT after vac-cination with the vaccine ChAdOx1 (AstraZeneca) but also older women. Conclusion of the Ger-man Society of Neurology: Although the overall risk of CVT after vaccination with ChAdOx1 is very low, individuals of all ages, especially women, should be fully informed about CVT as a possible adverse reaction to this vaccine.